A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma

A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma

<p>Abstract</p> <p>We present a generic dendritic cell (DC) vaccine strategy for patients with renal cell carcinoma (RCC) based on the use of RNA as a source of multiplex tumor-associated antigens (TAAs). Instead of preparing RNA from tumor tissue of each individual RCC patient, we...

Full description

Bibliographic Details
Main Authors: Noessner Elfriede, Weinzierl Andreas, Regn Sybille, Geiger Christiane, Schendel Dolores J
Format: Article
Language:English
Published: BMC 2005-07-01
Series:Journal of Translational Medicine
Subjects:
dendritic cells
tumor-derived RNA
renal cell carcinoma
tumor vaccine
immunotherapy
Online Access:http://www.translational-medicine.com/content/3/1/29

Internet

http://www.translational-medicine.com/content/3/1/29

Similar Items